Scientists are trying to tackle Alzheimer's from all angles, and a new study adds to the growing evidence that semaglutide, a widely used diabetes and weight loss drug, could also be beneficial in easing some of the disease's symptoms.

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.